| |
References:
Punch J, Rees R, Cahmaer B, et al: Acute lung injury following reperfusion after ischemia in the hind limbs of rats. J Traum a, 1991, 31: 760-5.
1. |
Concannon MJ, Dooley TW, Puckett CL : Improved survival ina replantation model containing ischemic muscle. Microsurgery , 1991, 12: 18-22. |
2. |
Brunelli GA, Vigasio V, Brunelli F : Muscular elementarization in ``critical`` replantations and revascularizations of the forearms. Ann Chir Main , 1985, 4:337-339. |
3. |
Brunelli GA, Brunelli GB :Tissue changes at different periods of ischemia. Interna Angiol, 1995, 14:253-263. |
4. |
Sternberg MJ, Tuttle TM, Makhoul RG, et al.: Postischemic extremities exhibit immediate release of tumor necrosis factor. J Vasc Surg, 1994,20:474-481. |
5. |
5. Sun JS, Tsung YH, Hou SM, et al.: Biochemical and histopathological changes in the mortality caused by acute ischemic limb injury. 1997.unpublished. |
6. |
Kausner JM, Anner H, Paterson IS, et al. : Lower torso ischemia-induced lung injury is leukocyte dependent. Ann Surg , 1988, 208: 762-767. |
7. |
Anner H, Kaufman RP, Kobzik L, et al : Pulmonary hypertension and leuko-sequestration after lower torso ischemia. Ann Surg , 1987, 206:642-648. |
8. |
Fantini GA, Conte MS : Pulmonary failure following lower torso ischemia: clinical evidence for a remote effect of reperfusion injury. Am Surgeon , 1995, 61:316-319. |
9. |
Weiss AC, Carey LA, Randoph MA, et al: Oxygen radical scavengers improve vascular patency and bone-muscle cell survival in an ischemic extremity replant model. Plast Reconstr Surg , 1989, 84: 117-128. |
10. |
Anderson GL, Acland RD, Siemionow M, et al: Vascular isolation of the rat cremaster muscle. Microvasc Res , 1988, 36: 56-63. |
11. |
Dorthe K, Kim MK, Barker JH: Direct visualization and measurement of wound neovascularization: Application in microsurgery research. Microcirculation , 1994,15:390-8 |
12. |
Papenfuss D, Gross JF, Intaglietta M, Treese FA: A transparent access chamber for the rat dorsal skin fold. Microvasc Res, 1979, 18: 311-8 |
13. |
Frank JM, Kansko S, Joel C, Barker JH: Microcirculatory research, angiogenesis, and microsurgery. Microcurgery, 1994, 15: 399-404 |
14. |
Punch J, Rees R, Cahmaer B, et al: Acute lung injury following reperfusion after ischemia in the hind limbs of rats. J Traum a, 1991, 31: 760-5. |
15. |
Akhilesh Randey, Matthias Mann. Proteomics to study genes and genomics. Nature ,2000, 405; 837-846. |
16. |
Kathryn S Lilley, Azam Razzaq, Paul Dupree. Two-dimensional gel electrophoresis: recent advances in sample preparation, detection and quantitation. Current Opinion in Chemical Biology , 2001, 6:46-50. |
17. |
Soren Naaby-Hansen, Michael D Waterfield, Ranier Cramer. Proteomics: post-genomic cartography to understand gene function. Trends in Phamacological Science , 2001,22(7): 376-384. |
18. |
Wenjun Mo, Barry L Karger. Analytical aspects of mass spectrometry and proteomics. Analytical Techniques , 2002,6:666-675. |
19. |
Mitsuaki Yanagida. Functional proteomics; current achievements. J of Chromatography B . 2002, 771:89-106. |
20. |
Timothy J.Griffin, Ruedi Aebersold. Advances in Proteome analysis by mass spectrometry. J of Biological Chemistry , 2001,276:45497-45500. |
21. |
Andreas Wattenberg, Andrew J.Orgn, Klaus Schneider, Richard Tyldesley, Robert Bordoli, Robert H.Bateman. Sequence dependent fragmentation of peptides generated by MALDI Quadrupole Time-of-Flight (MALDI Q-TOF) Mass spectrometry and its implications for protein identification. J Am Soc Mass Spectrom , 2002,13:772-783. |
22. |
Alfred L Yergey, Jens R Coorssen, Peter S Backlund, jr., Paul S Blank, Glen A Humphrey, Joshua Zimmerberg, Jennifer M Campbell, Marvin L Vestak. De novo sequencing of peptides using MALDI/TOF-TOF. Am Soc for Mass Spectro , 2002,13:784-791. |
23. |
Hanno Steen, Akhilesh Pandey. Proteomic goes quantitative: measuring protein abundance. Trends in Biotech .,2002,20:361-3 |
24. |
Wayne F Patton Detection technologies in proteome analysis. J of Chromatography B ., 2002,771:3-31 |
25. |
Timothy J Griffin, and Lloyd M Smith Single-nucleotide polymorphism analysis by MALDI-TOF mass spectrometry. TIBTECH,2000,18:77-84. |
26. |
Joshua N Adkins, Susan M Varnum, Kenneth J Auberry, Ronald J Moore, Nicolas H Angell, Richard D Smith, David L Springer, Joel G Pounds. Toward a human serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Molecular & Cellular Proteomics , 2002,1:947-955. |
27. |
Adeline R Whitney, Maximilian Diehn, Stephen J Popper, Ash A Alizadeh, Jennifer C Boldrick, David A Relman, Patrick O Brown Individuality and variation in gene expression patterns in human blood. PNAS , 2003,100:1896-1901. |
28. |
N Leigh Anderson, Norman G Anderson. The human plasma proteome History, character, and diagnostic prospects. Molecular & Cellular Proteomics , 2002,1:845-867. |
29. |
Zhu Y and Prada LF. Neurofibromin, a tumor suppressor in the nervous system. Exp.Cell Re s, 2001,264: 19-28. |
30. |
Cichowski K and Jacks T. NF1 tumor suppressor gene function:narrowing the GAP. Cell , 2001, 104:593-604. |
31. |
Friedman JM. Epidemiology of neurofibromatosis type 1. Am.J.Med.Genet., 1999,89: 1-6. |
32. |
Martin GA.et al.. The GAP-related domain of the neurfibromstosis type I gene product interacts with ras p21. Cell, 1990, 63: 843-849. |
33. |
Xu GF.et.al. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and omplements iramutants od S. cerevisiae. Cell, 1990, 63:835-841. |
34. |
Ballester R. et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell, 1990, 63:851-859. |
35. |
Guo HF, et al. Requirement of Drosphila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science 1997, 276:795-798. |
36. |
Guo HF et al. A neurofibromatosis-1-regulated pathway is required pathway for learning in Drosphila. Nature, 2000, 895-898. |
37. |
Xu H and Gutmann DH. Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules. Brain Res , 1997, 759: 149-152. |
|
